Mairs & Power’s Cardiovascular Systems CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-166,953
| Closed | -$3.14M | – | 230 |
|
|
2021
Q4 | $3.14M | Sell |
166,953
-107
| -0.1% | -$2.86K | 0.03% | 108 |
|
|
2021
Q3 | $5.48M | Sell |
167,060
-259
| -0.2% | -$9.7K | 0.05% | 93 |
|
|
2021
Q2 | $7.14M | Buy |
167,319
+9,010
| +6% | +$352K | 0.07% | 89 |
|
|
2021
Q1 | $6.07M | Buy |
158,309
+24,009
| +18% | +$1.02M | 0.06% | 95 |
|
|
2020
Q4 | $5.88M | Buy |
134,300
+7,095
| +6% | +$267K | 0.07% | 93 |
|
|
2020
Q3 | $5.01M | Buy |
127,205
+6,130
| +5% | +$198K | 0.06% | 93 |
|
|
2020
Q2 | $3.82M | Sell |
121,075
-3,900
| -3% | -$146K | 0.05% | 101 |
|
|
2020
Q1 | $4.4M | Buy |
124,975
+21,175
| +20% | +$893K | 0.06% | 94 |
|
|
2019
Q4 | $5.04M | Buy |
103,800
+4,460
| +4% | +$203K | 0.06% | 103 |
|
|
2019
Q3 | $4.72M | Buy |
99,340
+2,058
| +2% | +$96.7K | 0.06% | 101 |
|
|
2019
Q2 | $4.18M | Buy |
97,282
+1,878
| +2% | +$72.9K | 0.05% | 105 |
|
|
2019
Q1 | $3.69M | Buy |
95,404
+12,292
| +15% | +$417K | 0.04% | 105 |
|
|
2018
Q4 | $2.37M | Buy |
83,112
+7,150
| +9% | +$227K | 0.03% | 111 |
|
|
2018
Q3 | $2.97M | Sell |
75,962
-5,200
| -6% | -$192K | 0.03% | 109 |
|
|
2018
Q2 | $2.62M | Hold |
81,162
| – | – | 0.03% | 107 |
|
|
2018
Q1 | $1.78M | Hold |
81,162
| – | – | 0.02% | 111 |
|
|
2017
Q4 | $1.92M | Buy |
81,162
+5,400
| +7% | +$136K | 0.02% | 106 |
|
|
2017
Q3 | $2.13M | Hold |
75,762
| – | – | 0.03% | 108 |
|
|
2017
Q2 | $2.44M | Hold |
75,762
| – | – | 0.03% | 104 |
|
|
2017
Q1 | $2.14M | Hold |
75,762
| – | – | 0.03% | 109 |
|
|
2016
Q4 | $1.83M | Sell |
75,762
-240
| -0.3% | -$5.89K | 0.02% | 109 |
|
|
2016
Q3 | $1.8M | Sell |
76,002
-45,200
| -37% | -$990K | 0.02% | 108 |
|
|
2016
Q2 | $2.23M | Sell |
121,202
-125,000
| -51% | -$1.95M | 0.03% | 98 |
|
|
2016
Q1 | $2.55M | Hold |
246,202
| – | – | 0.04% | 94 |
|
|
2015
Q4 | $3.72M | Buy |
246,202
+38,570
| +19% | +$573K | 0.06% | 88 |
|
|
2015
Q3 | $3.29M | Buy |
207,632
+73,450
| +55% | +$1.85M | 0.05% | 87 |
|
|
2015
Q2 | $3.55M | Buy |
134,182
+15,760
| +13% | +$509K | 0.05% | 86 |
|
|
2015
Q1 | $4.62M | Hold |
118,422
| – | – | 0.06% | 79 |
|
|
2014
Q4 | $3.56M | Buy |
118,422
+6,580
| +6% | +$188K | 0.05% | 81 |
|
|
2014
Q3 | $2.64M | Buy |
+111,842
| New | +$3.18M | 0.04% | 86 |
|
Other funds holding CSII
Mairs & Power's CSII Position: Q1 2022 in Review
Mairs & Power sold out of Cardiovascular Systems (CSII) in Q1 2022, closing a stake of 166,953 shares — an estimated $3.14M sold.
Mairs & Power first reported a position in CSII in Q3 2014 and held it in 30 quarters. The position peaked at $7.14M in Q2 2021. 174 funds tracked by Wall St. Rank hold CSII as of Q1 2022.
- Mairs & Power reported no remaining Cardiovascular Systems position as of Q1 2022 after selling out during the quarter.
- Mairs & Power sold 166,953 Cardiovascular Systems shares in Q1 2022, an estimated $3.14M.
- Mairs & Power first reported a position in Cardiovascular Systems in Q3 2014 and held it in 30 quarters.
- Mairs & Power's Cardiovascular Systems position peaked at $7.14M in Q2 2021.
- 174 funds tracked by Wall St. Rank held Cardiovascular Systems as of Q1 2022.
Based on Mairs & Power's 13F filing for Q1 2022, filed 16 May 2022.